Connecting London’s Life Sciences ecosystem for scale

17 November 2026

The London Life Sciences Strategy sets out a bold direction for making the capital a world-leading hub for developing, adopting and scaling healthcare innovation.

To mark London Life Sciences Week, Rishi Das-Gupta, Chief Executive at the HIN, outlines how the strategy’s programmes for change will be strengthened by the pioneering London Health Innovation Zone, creating clearer routes for cutting-edge innovation to deliver benefits for patients, communities, staff and the economy.

London has no shortage of promising digital health innovations, but demonstrating the value of a product is only part of the challenge. Too often, solutions that have generated evidence in one setting do not have sufficient evidence to be adopted in adjacent areas and become stuck in a cycle of repetitive pilots. With pressures to balance procurement opportunities with business growth and investor expectations, many high-potential companies are often lost to this complex procurement pathway.

London is pioneering working as a Health Innovation Zone (HIZ) in order to improve how it supports companies that have the potential to address some of the capital’s biggest health challenges. The HIZ is designed to improve how London operates as a good customer to accelerate improvements in health and foster economic growth.

A connected innovation ecosystem

London already has a vibrant innovation ecosystem with support programmes, such as DigitalHealth.London and Mindset-XR, helping startups to build the skills, knowledge, evidence base for procurement and connections to navigate the system. However, the scale and (relative) complexity of the health system in the capital presents opportunities and challenges for companies. A repeated theme in our conversations with innovators is how to break out of pilots and move to procurement at scale.

Connecting London’s life sciences ecosystem through the London Health Innovation Zone (HIZ) is key to enabling this change, shifting the focus to needs-led transformation to realise benefits for patients and staff sooner.

The exciting development of the Health Innovation Zone is part of the agenda at London Life Sciences Week. This coordinated approach is designed to connect the capital’s life sciences ecosystem, improving how procurement, regulation, funding and evaluation aligns to accelerate adoption. The London Problem Book for Health Innovation aims to give innovators a clearer view of the challenges facing London, while a live directory for funding opportunities could make it easier for innovators to find the right support at the right stage.

Further programmes that we are supporting, like the London Secure Data Environment and MHRA AI Regulatory Sandbox, are exploring how innovators can respond to real-world need to tackle health inequalities and address longstanding healthcare challenges for Londoners. At the HIN, we have already seen the potential of this pan-London working, helping the London Secure Data Environment include data from over 1,076 GP surgeries to link records for more than 10.5 million patients across the capital.

Moving beyond individual pilots

The challenge remains: how can we ensure that successful testing leads to adoption and scale further down the line? The string of repeated pilots can only take things so far, and the greater opportunity lies in creating a clearer route for innovations to be adopted at scaled across the NHS. The HIZ outlines two approaches, depending on whether the best way to scale-up is to move organisation by organisation or to adopt across London in one step.

Ideally, an effective innovation pathway would gather evidence at each stage, supporting progress towards the next, instead of being repeatedly recreated. To achieve this, we need to be clearer about what we are trying to achieve when we pilot an innovation. Is the aim to test whether an emerging technology works? To establish its value at scale, including its impact on the workforce, populations and the economy? Or to address a specific healthcare challenge?

Firstly, Innovator Passports will help to answer these questions from the beginning of an innovation journey. The passports will also cover technical risks and regulatory compliance, meaning that this information will not need to be submitted repeatedly by companies. This leaves healthcare provider organisations like NHS Trusts to focus on operational implementation – which varies for each setting – rather than focusing on understanding the technical risk – which is similar in many settings.

Secondly, a more strategic approach to procurement will enable providers and commissioners align contract terms and priorities, enabling easier integration at a larger scale. Getting this right could transform how we think about adoption and scale on a local, regional and national scale. By standardising expectations across the healthcare system, we can establish pilots as tools to:

  • Test a concept;
  • Test value at scale; or
  • Refine an implementation approach.

Our recent work supporting the procurement of Ambient Voice Technology (AVT) in south west London demonstrates how this could work in practice. By collating insights and lessons from the procurement activity across trusts, other NHS organisations can make informed decisions about procuring emerging technologies, even in rapidly developing markets.

Ambition into action

London has been a global health innovation hub for many years – but the changes announced as part of the Life Sciences Week including access to coordinated funding, improved procurement, using data to support testing and the coordination of pilots to prevent companies and healthcare providers having to duplicate effort will have a positive knock-on effect nationally for our health and care economy. A system that brings together NHS organisations, health innovation networks, academic institutions and the wider life sciences community, is one that can help to achieve a thriving innovation ecosystem.

For London Life Sciences Week, we are bringing this cross-sector working to life through the “Unlocking London’s Health Innovation Opportunity” session, delivered with UCLPartners and Imperial College Health Partners. We will be exploring the key opportunities that cross-sector collaboration can bring to accelerate health innovation, as well as how the London Health Innovation Zone serves as a key enabler of an interconnected health and life sciences ecosystem.

Not only will fostering these connections and opportunities enable us to retain UK-based companies headquartered in London, but it will also attract more international talent. This will further boost our economy as well as benefit our population, granting patients faster access to some of the most cutting-edge innovations from around the globe.

Find out more

To learn more about the London Life Sciences Strategy and how the system is working together through the Health Innovation Zone, please get in touch.